Hypoxia, iron, and ferroptosis: a novel perspective on pheochromocytoma progression and therapy
Exploiting mutation-specific dysregulation of iron metabolism to trigger ferroptosis may provide a novel therapeutic strategy for therapy-resistant pheochromocytomas.
Authors
- Sawako Suzuki (ORCID: https://orcid.org/0000-0001-6774-8070)
- Shinichi Sakamoto (ORCID: https://orcid.org/0000-0002-7508-7521)
- Hisashi Koide (ORCID: https://orcid.org/0000-0002-8545-7530)
- Tomohiko Ichikawa (ORCID: https://orcid.org/0000-0002-8637-4163)
- Kazuki Ishiwata
- Yusuke Imamura (ORCID: https://orcid.org/0009-0006-7207-1520)
- Katsushi Igarashi
- Akiko Ishida
- Suzuka Watanabe
- Koutaro Yokote (ORCID: https://orcid.org/0000-0003-3033-4813)
- Yoshihito Ozawa (ORCID: https://orcid.org/0000-0002-5835-8932)
- Yutaro Ruike
- Masafumi Sugo
- Masanori Fujimoto (ORCID: https://orcid.org/0000-0003-1458-8207)
- Kohei Takahashi (ORCID: https://orcid.org/0000-0002-9705-0201)
- Rei Hashimoto
- Kumiko Naito
- Jun-ichiro Ikeda
Institutions
- Chiba University (JP)
- Chiba University Hospital (JP)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1093/ejendo/lvaf248
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00